BioAesthetics

BioAesthetics is a US-based biotechnology company specializing in tissue-engineered solutions for breast reconstruction. Founded in 2015 as a Tulane University spin-out, we develop innovative products to improve outcomes for patients undergoing mastectomies.

Our initial product, a patent-pending tissue-engineered nipple-areolar complex (NAC), provides surgeons with an off-the-shelf, acellular graft. This NAC acts as a building frame, stimulating the patient’s own tissue regeneration to create a natural-looking nipple and areola.

BioAesthetics is currently in the pre-clinical phase, dedicated to advancing this groundbreaking technology and offering a significant advancement in reconstructive surgery. We are committed to providing healthcare providers with a reliable and effective solution for breast cancer patients.

We serve plastic and reconstructive surgeons seeking enhanced options for their patients, addressing a critical need in the field of breast reconstruction.